![]() |
|
|
Vol. 53, Issue 3, 530-538, March 1998
-Aminobutyric Acid Type A Receptor
Distinct from That for Isoflurane
Departments of
Anesthesia and Critical Care (C.E.R., Q.Y., S.E.F.,
N.L.H.) and
Pharmacological and Physiological Sciences (V.V.K.,
N.L.H.), and
Committee on Neurobiology (M.D.K.), University of Chicago,
Chicago, Illinois 60637
Both volatile and intravenous general anesthetics allosterically
enhance
-aminobutyric acid (GABA)-evoked chloride currents at the
GABA type A (GABAA) receptor. Recent work has revealed that
two specific amino acid residues within transmembrane domain (TM)2 and
TM3 are necessary for positive modulation of GABAA and glycine receptors by the volatile anesthetic enflurane. We now report
that mutation of these residues within either GABAA
2 (S270 or A291) or
1 (S265 or M286) subunits resulted in receptors that retain normal or near-normal gating by GABA but are insensitive to
clinically relevant concentrations of another inhaled anesthetic, isoflurane. To determine whether receptor modulation by intravenous general anesthetics also was affected by these point mutations, we
examined the effects of propofol, etomidate, the barbiturate methohexital, and the steroid alphaxalone on wild-type and mutant GABAA receptors expressed in human embryonic kidney 293 cells. In most cases, these mutations had little or no effect on the actions of these intravenous anesthetics. However, a point mutation in
the
1 subunit (M286W) abolished potentiation of GABA by propofol but
did not alter direct activation of the receptor by high concentrations of propofol. These data indicate that the receptor structural requirements for positive modulation by volatile and intravenous general anesthetics may be quite distinct.
This article has been cited by other articles:
![]() |
A. Saras, G. Gisselmann, A. K. Vogt-Eisele, K. S. Erlkamp, O. Kletke, H. Pusch, and H. Hatt Histamine Action on Vertebrate GABAA Receptors: DIRECT CHANNEL GATING AND POTENTIATION OF GABA RESPONSES J. Biol. Chem., April 18, 2008; 283(16): 10470 - 10475. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-Y. Li, C. Xiao, M. Xiong, E. Delphin, and J.-H. Ye Nanomolar Propofol Stimulates Glutamate Transmission to Dopamine Neurons: A Possible Mechanism of Abuse Potential? J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 165 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Q. Hu and R. W. Peoples Arginine 246 of the Pretransmembrane Domain 1 Region Alters 2,2,2-Trichloroethanol Action in the 5-Hydroxytryptamine3A Receptor J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1011 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jia, M. Yue, D. Chandra, G. E. Homanics, P. A. Goldstein, and N. L. Harrison Isoflurane Is a Potent Modulator of Extrasynaptic GABAA Receptors in the Thalamus J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1127 - 1135. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Barann, I. Linden, S. Witten, and B. W. Urban Molecular Actions of Propofol on Human 5-HT3A Receptors: Enhancement as Well as Inhibition by Closely Related Phenol Derivatives Anesth. Analg., March 1, 2008; 106(3): 846 - 857. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zeller, M. Arras, R. Jurd, and U. Rudolph Identification of a Molecular Target Mediating the General Anesthetic Actions of Pentobarbital Mol. Pharmacol., March 1, 2007; 71(3): 852 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.-D. Li, D. C. Chiara, G. W. Sawyer, S. S. Husain, R. W. Olsen, and J. B. Cohen Identification of a GABAA Receptor Anesthetic Binding Site at Subunit Interfaces by Photolabeling with an Etomidate Analog. J. Neurosci., November 8, 2006; 26(45): 11599 - 11605. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Sato, N. Seo, and E. Kobayashi Ethanol-Induced Hypnotic Tolerance Is Absent in N-Methyl-d-Aspartate Receptor {varepsilon}1 Subunit Knockout Mice. Anesth. Analg., July 1, 2006; 103(1): 117 - 120. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. Sou, M.-H. Chan, and H.-H. Chen Ketamine, but not propofol, anaesthesia is regulated by metabotropic glutamate 5 receptors Br. J. Anaesth., May 1, 2006; 96(5): 597 - 601. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Erden, Z. Yangin, K. Erkalp, H. Delatioglu, F. Bahceci, and A. Seyhan Increased Progesterone Production During the Luteal Phase of Menstruation May Decrease Anesthetic Requirement Anesth. Analg., October 1, 2005; 101(4): 1007 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Fisher The {alpha}1 and {alpha}6 subunit subtypes of the mammalian GABAA receptor confer distinct channel gating kinetics J. Physiol., December 1, 2004; 561(2): 433 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Caraiscos, J. G. Newell, K. E. You-Ten, E. M. Elliott, T. W. Rosahl, K. A. Wafford, J. F. MacDonald, and B. A. Orser Selective Enhancement of Tonic GABAergic Inhibition in Murine Hippocampal Neurons by Low Concentrations of the Volatile Anesthetic Isoflurane J. Neurosci., September 29, 2004; 24(39): 8454 - 8458. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Lobo, M. P. Mascia, J. R. Trudell, and R. A. Harris Channel Gating of the Glycine Receptor Changes Accessibility to Residues Implicated in Receptor Potentiation by Alcohols and Anesthetics J. Biol. Chem., August 6, 2004; 279(32): 33919 - 33927. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ahrens, G. Haeseler, M. Leuwer, B. Mohammadi, K. Krampfl, R. Dengler, and J. Bufler 2,6 Di-tert-butylphenol, a Nonanesthetic Propofol Analog, Modulates {alpha}1{beta} Glycine Receptor Function in a Manner Distinct from Propofol Anesth. Analg., July 1, 2004; 99(1): 91 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Miko, E. Werby, H. Sun, J. Healey, and L. Zhang A TM2 Residue in the {beta}1 Subunit Determines Spontaneous Opening of Homomeric and Heteromeric {gamma}-Aminobutyric Acid-gated Ion Channels J. Biol. Chem., May 28, 2004; 279(22): 22833 - 22840. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Rusch, H. Zhong, and S. A. Forman Gating Allosterism at a Single Class of Etomidate Sites on {alpha}1{beta}2{gamma}2L GABAA Receptors Accounts for Both Direct Activation and Agonist Modulation J. Biol. Chem., May 14, 2004; 279(20): 20982 - 20992. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. B. Gonzales, C. L. Bell-Horner, M. A. M. de la Cruz, J. A. Ferrendelli, D. F. Covey, and G. H. Dillon Enantioselectivity of {alpha}-Benzyl-{alpha}-methyl-{gamma}-butyrolactone-Mediated Modulation of Anticonvulsant Activity and GABAA Receptor Function J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 677 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bali and M. H. Akabas Defining the Propofol Binding Site Location on the GABAA Receptor Mol. Pharmacol., January 1, 2004; 65(1): 68 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-s. S. Chang, R. Olcese, and R. W. Olsen A Single M1 Residue in the {beta}2 Subunit Alters Channel Gating of GABAA Receptor in Anesthetic Modulation and Direct Activation J. Biol. Chem., October 31, 2003; 278(44): 42821 - 42828. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Flaishon, A. A. Weinbroum, L. Veenman, S. Leschiner, V. Rudick, and M. Gavish Flumazenil Attenuates Development of Tolerance to Diazepam After Chronic Treatment of Mice with Either Isoflurane or Diazepam Anesth. Analg., October 1, 2003; 97(4): 1046 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Harrison Knockin' on the Door of General Anesthetic Mechanisms: But Will U.S. Researchers Be Shut Out? Anesth. Analg., September 1, 2003; 97(3): 616 - 618. [Full Text] [PDF] |
||||
![]() |
R. Darbandi-Tonkabon, W. R. Hastings, C.-M. Zeng, G. Akk, B. D. Manion, J. R. Bracamontes, J. H. Steinbach, S. J. Mennerick, D. F. Covey, and A. S. Evers Photoaffinity Labeling with a Neuroactive Steroid Analogue. 6-AZI-PREGNANOLONE LABELS VOLTAGE-DEPENDENT ANION CHANNEL-1 IN RAT BRAIN J. Biol. Chem., April 4, 2003; 278(15): 13196 - 13206. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kitamura, W. Marszalec, J. Z. Yeh, and T. Narahashi Effects of Halothane and Propofol on Excitatory and Inhibitory Synaptic Transmission in Rat Cortical Neurons J. Pharmacol. Exp. Ther., January 1, 2003; 304(1): 162 - 171. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Pain, S. Gobaille, C. Schleef, D. Aunis, and P. Oberling In Vivo Dopamine Measurements in the Nucleus Accumbens After Nonanesthetic and Anesthetic Doses of Propofol in Rats Anesth. Analg., October 1, 2002; 95(4): 915 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Williams and M. H. Akabas Structural Evidence that Propofol Stabilizes Different GABAA Receptor States at Potentiating and Activating Concentrations J. Neurosci., September 1, 2002; 22(17): 7417 - 7424. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. W. Miller The nature of sites of general anaesthetic action Br. J. Anaesth., July 1, 2002; 89(1): 17 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Burke and D. J. Henderson Chirality: a blueprint for the future Br. J. Anaesth., April 1, 2002; 88(4): 563 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
P J Hutchinson, M T O'Connell, P G Al-Rawi, C R Kett-White, A K Gupta, L B Maskell, J D Pickard, and P J Kirkpatrick Increases in GABA concentrations during cerebral ischaemia: a microdialysis study of extracellular amino acids J. Neurol. Neurosurg. Psychiatry, January 1, 2002; 72(1): 99 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.M. Menon Editorial I: Mapping the anatomy of unconsciousness--imaging anaesthetic action in the brain Br. J. Anaesth., May 1, 2001; 86(5): 607 - 617. [Full Text] [PDF] |
||||
![]() |
M. T. Alkire and R. J. Haier Correlating in vivo anaesthetic effects with ex vivo receptor density data supports a GABAergic mechanism of action for propofol, but not for isoflurane{{dagger}} {{ddagger}} Br. J. Anaesth., May 1, 2001; 86(5): 618 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Krasowski, A. Jenkins, P. Flood, A. Y. Kung, A. J. Hopfinger, and N. L. Harrison General Anesthetic Potencies of a Series of Propofol Analogs Correlate with Potency for Potentiation of {gamma}-Aminobutyric Acid (GABA) Current at the GABAA Receptor but Not with Lipid Solubility J. Pharmacol. Exp. Ther., April 1, 2001; 297(1): 338 - 351. [Abstract] [Full Text] |
||||
![]() |
G. Hapfelmeier, W. Zieglgansberger, R. Haseneder, H. Schneck, and E. Kochs Nitrous Oxide and Xenon Increase the Efficacy of GABA at Recombinant Mammalian GABAA Receptors Anesth. Analg., December 1, 2000; 91(6): 1542 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. X. Carlson, A. C. Engblom, U. Kristiansen, A. Schousboe, and R. W. Olsen A Single Glycine Residue at the Entrance to the First Membrane-Spanning Domain of the gamma -Aminobutyric Acid Type A Receptor beta 2 Subunit Affects Allosteric Sensitivity to GABA and Anesthetics Mol. Pharmacol., March 1, 2000; 57(3): 474 - 484. [Abstract] [Full Text] |
||||
![]() |
V. V. Koltchine, S. E. Finn, A. Jenkins, N. Nikolaeva, A. Lin, and N. L. Harrison Agonist Gating and Isoflurane Potentiation in the Human gamma -Aminobutyric Acid Type A Receptor Determined by the Volume of a Second Transmembrane Domain Residue Mol. Pharmacol., November 1, 1999; 56(5): 1087 - 1093. [Abstract] [Full Text] |
||||
![]() |
T. Yamakura, S. J. Mihic, and R. A. Harris Amino Acid Volume and Hydropathy of a Transmembrane Site Determine Glycine and Anesthetic Sensitivity of Glycine Receptors J. Biol. Chem., August 13, 1999; 274(33): 23006 - 23012. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ueno, J. R. Trudell, E. I Eger II, and R. A. Harris Actions of Fluorinated Alkanols on GABAA Receptors: Relevance to Theories of Narcosis Anesth. Analg., April 1, 1999; 88(4): 877 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Beckstead, R. Phelan, and S. J. Mihic Antagonism of Inhalant and Volatile Anesthetic Enhancement of Glycine Receptor Function J. Biol. Chem., June 29, 2001; 276(27): 24959 - 24964. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jenkins, E. P. Greenblatt, H. J. Faulkner, E. Bertaccini, A. Light, A. Lin, A. Andreasen, A. Viner, J. R. Trudell, and N. L. Harrison Evidence for a Common Binding Cavity for Three General Anesthetics within the GABAA Receptor J. Neurosci., March 15, 2001; 21(6): RC136 - RC136. [Abstract] [Full Text] [PDF] |
||||